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The limited number of Langerhans cells (LC) in the epi-
dermis is one of the main reasons for the technical diffi-
culties in resolving the question of LC kinetics . In the pres-
ent paper, we describe a method to evaluate the LC replication 
potential in epidermis. The procedure is based on the spe-
CIfic. incorporation of bromodeoxyuridine (BrdU), a thy-
mldl11e analogue, into the DNA during the S-phase of the 
cell cycle. Mice, bearing human skin grafts, were injected 
s:c. every 6 h for up to 17 days with BrdU. At different 
times, the incorporated BrdU as well as the human epi-
dermal LC were revealed on skin sections using anti-BrdU 
~nd OKT-6 monoclonal antibodies, respectively. After 6 
, 4.9% of the LC were labeled with BrdD. Then, the 
number ofOKT-6(+) BrdU(+) cells increased in a linear 
manner and achieved 34% at 120 h, 67% at 240 h , and 
94% at 400 h during the course of continuous labeling 
procedures. Based on tillS result we calculated a total cell 
cycle time of 392 h (16.3 days) and 12 h for the S-phase 
for human epidermal LC. 
Applying this technique, we were able to show also that 
48 h after local treatment with 12-0-tetradecanoylphorbol-
13-acetate or after stripping, the number of BrdU-labeled 
LC was considerably increased. Furthermore, after i. p . in-
jection of colchicine in the nude mouse, human epidermal 
LC undergoing mitosis were evidenced by electron mi-
croscopy in the graft. From these results we conclude that 
the LC are actively cycling-therewith a self-reproducin g 
cell population in human epidermis. J Invest Dermatol 88:17-
20, 1987 
--------------------------------------------------------------------------------------------------------
O ur previous flow-cytometric study, performed on normal human epidermal cell suspensions double stained with OKT -6 monoclonal antibody and DNA dye, demonstrated that OKT-6( +) Langer-f hans cells (LC) m ay be found in different phases 
of the cell cycle [1] . Although we showed that the DNA content 
°hhuman LC varied according to the different cell cycle phases , 
t IS study did not answer the question as to whether human 
epidermal LC may actively cycle in the epidermis. 
d The detection of replicating cells is usually accomplished by 
emonstrating [3H]thymidine incorporation into DNA by au-
t~tadlography. This method is time-consuming and does not 
a ;:.W ll1vestigations of the minor cell populations such as LC, 
w lch have to be identified simultaneously by immunologic markers 
Or electron microscopy. 
/n the present study, bromodeoxyuridine (BrdU), an analogue ~_ t~ymidine that incorporates specifically into DNA during the 
P ase of the cell cycle, was used to estimate the LC replicating 
ho~entlal in human skin grafted onto the nude mouse. An anti-
r U monoclonal antibody coupled with fluorescein isothio-
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Abbreviatio~s: 
BrdU: bromodeoxyuridine 
F(TC: fluorescein isothiocyanate 
LC: Langerhans cell(s) 
~BS: Phosphate~buffered saline 
T EM: transmiSSIOn electron microscopy 
PA: 12-0-tetradecanoylphorbol-13-acetatc 
cyana te (FITC) was then applied on skin sections to identify cells 
having achieved DNA synthesis. A parallel application of OKT-
6 monoclonal antibody as a marker of LC allowed us to estimate 
the number of BrdU-labeled LC. Consequently, the number of 
LC in S-phase was evaluated at different times durin g a contin-
uous BrdU labeling procedure (up to 17 days) as well as after 
stripping or local 12-0-tetradecanoylphorbol-13-aceta te (TPA) 
application. In addition, experiments to investigate a LC undergo-
ing mitosis were performed. 
MA TERIALS AND METHODS 
Continuous BrdU Labeling Procedure Pathogen-free, con-
genitally athymic ("nude") mice (Swiss, nu/ nu , Iffa Credo, Les 
Onc;ins, France) were grafted with normal human skin as pre-
viously described [2]. Two-month-old grafts were used in the 
study. Every 6 h during 17 days, 1 mg ofBrdU diluted into 0.2 
ml of saline was injected s.c, in mice. After various times (6,12, 
24, 48, 72, 96, 120, 180,240, and 400 h) the animals were sacrificed 
and the grafts excised. Immediately following removal, they were 
quickly frozen in liquid nitrogen (0.5 h) and then stored at -80°C 
until sectioning. 
In additional experiments, 48 h before BrdU injection, grafted 
skin was either treated with 100 nmo\ of TPA or stripped (20 
strips). Six hours after BrdU injection, grafts were removed, 
frozen, and processed for immunofluorescence study . As control, 
untreated grafts were used. Two skin grafts originating from 
different human donors were used to establish LC BrdU incor-
poration either at each time point of continuous labeling or after 
local applications. 
Immunofluorescence Study Five micron-thick, cryostat skin 
sections were prepared and an OKT-6 monoclonal antibody (Or-
tho, Raritan, New Jersey) diluted 1:10 was used for LC staining. 
This was followed by rabbit antimouse IgGl (Nordic, The Neth-
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erl ands) d iluted 1 :30 and tetramethylrh odamine isothiocyanate 
(TR ITC)-conju gated swine antirabbit IgG (Daco, Denmark) di-
luted 1 :100. All incubati ons lasted 45 min, were fo llowed by 10-
min washes in PBS, an d perform ed at room tempera ture. 
To iden tify simul ta neously the cell s th at incorporated BrdU, 
the sk in sections were treated with 4 N H C 1 (5 min) fo ll owed by 
1 O-min washes in 0.1 M sodium tetraborate, pH 8.5 , and thereafter 
in phosphate-buffered sa line (PBS). Then, secti ons were incu-
bated for 45 min with FITC-conjugated an ti-Brd U monoclonal 
antibody (Becton-Dickinson, Mo untain View, Ca lifo rnia) di lu ted 
1 :10. After 2 subsequ ent washes in PBS, secti ons were mounted 
in PBS/glycerol and exa mined immedi ately after stainin g with a 
Zeiss epi-illumination Auorescence microscope fitted with Auo-
rescein and rhodamine selective filters. 
Contro ls were performed in the absence of either OKT-6 
monoclonal antibody trea tment o r o fBrd U injecti on . As a further 
contro l, OKT-6 antibody was replaced by monoclona l antibod y 
to cytokeratin component No. 18 (Boehringer, Mannheim , F.R.G .) 
w hi ch is as OKT-6 monoclonal, a mouse IgG I immunoglobulin. 
T he number of cell s that both inco rporated BrdU and showed 
OKT-6 specifi city (BrdU + OKT-6+) was related to th e total 
num ber of O KT -6( +) cell s and expressed as a mean percenta ge. 
On ly OKT-6( +) ceLI s with distinct cellular stru cture were in-
cluded and at leas t] 000 O KT -6( +) cell s were co unted fo r each 
graft. 
Transtnission Electron Microscopic (TEM) Study and LC 
Mitotic Activity Investigations To increase the probability 
of findin g a LC in mitosis, TPA-treated human skin g rafts were 
used for TEM exa mination. In addition , mi ce were injected i. p. 
w ith colchi cine (0.1 m g/O.] ml of sa line), a known metaphase 
blocker [3). Five hours later th e g rafts were rem o ved, small strips 
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were fi xed, treated with osmiulll, dehydrated, and embedded ill 
Epon acco rdin g to routin e TEM technique. Thereafter, 0.5-1.0 
J.l,m-thi ck sections were prepa red, stained w ith 1.0% to luidine 
blue, and observed by li ght microsco py (x 630). All suprabasal 
cells that showed a clear cytoplasm and mitotic figures were noted. 
Subsequently 300-500 A- thick sections were preparcd to observe 
these cells under th e electron microscope Oeol 1200 Ex.). 
RESULTS AND D ISCUSS ION 
In previ ous studies it has been documented by Kru eger et al [4,5) 
as wel l as by the authors [2) that th e LC in the hum an skin gra fted 
onto nud e mouse represent a sta ble cell population during a long 
period of time (we accomp lished our studies after 9 month s) . In 
addition , these LC continued to express th eir specifi c membrane 
antigens (HLA-DR and T -6) and penetration of murine LC into 
the human grafts was not observed. We used thi s model for 
biologic inves ti ga ti ons o f LC to elucidate cell cycle properties 
of LC. 
In hum an epidermis, which is multilayered, LC are found at 
two levcls. The majority of them are o bserved in the hi gher part 
of the epidermis, just below the stratum. granulosum. Other LC 
are situated in the lower third of the epiderl11 is, in basa l or just 
suprabasa l position. In human skin gra fts on nude nl.Oll Se, the 
sa me LC distribution was observed . The continuous labeling eX-
periments demonstrated that at th e beginning (up to 24 h) the 
doublc-st:l ined (BrdU + OKT -6 +) LC were 1110 re freq uently 
found in th e lower part of the epidermis. T hereafter, eq ual nu1l1-
bers of double-labeled LC were observed in the lower and higher 
regions of epidermis (Fig 1) . In :lddition, double-l abeled LC were 
o ften seen in pairs :IS has been already reported [6]. 
As demonstrated in Fig 2, the number of LC that inco rporated 
Figure 1. Double-stained skin sect io ns after 
96 (a,b) or 72 (c,d) h of repea ted BrdU in-
jections. a (/Ild c, OKT-6 mo noclonal antibOd~ 
was fo llowed by rabbit anti mo use IgG 1 ;111 
TRITC -conju ga ted swine antirabbit IgG. b 
alld d, After HC I treatment and pH eguill' 
bration, incorporated BrdU was revealed WIt" 
FITC-conjugatcd anti-BrdU monoclo nal an-
tibody. Arro\ll5 indicate double-sta ined LC. 
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~igure 2. Percentage o f B rd U- bbckd LC after repea ted B rd U inj ections. 
rdU was IIlJected s.c. every 6 h In to .the mouse bearing hum an skill 
gra fts. Its in co rpora tio n in to hum an LC (OKT -6 + ce ll s) was meas ured 
onskin sections at 6, 12,24,48,72, 96, 120, ISO, 240, and 400 h. Each 
PO IlII represents the mea n o f 2 meas urements on diffe rent hum an skin 
grafts. 
BrdU increased in a Iinca r mann cr during the coursc of contin-
lIOUs labeling experiments. T he characteristics of the curve ob-
~InCd with the 17-day experim ent sugges t thatall LC are cycl ing. 
. SS Ul11lng a ho mogelllCity ofLC population , different parameters 
~f the LC cell cycle can be read from the g raph and calcul ated, 
[;lerefore, with the proced ure described by Potten and Wichmann 
d . Accord ingly, the total cell cycle time for LC is 392 h (16.3 
Lays) and th e duration of the S-phase is 12 h . Finally, 3 .1 % of 
C Would be in S-phase at time zero, in agreement w ith our 
recent findin gs showing the mean percentage of LC in S-phase 
t,o be 2.9 ± 0.8% as eva luated by fl ow cytometry of fres h human 
epidermal cell suspensions [1] . 
/n previous studies, 13H]thymidine inco rporation in to the nuclei 
~I epidermal LC was observed but labelin g indices were low [8,9] . 
. leSe studies utili zing co mbined autoradiography and cytochem-
~:ry suffe r, however, from the un certainty of LC identification. 
le method that we app lied in the present study has been used 
r~odate for flow cy tometri c m easurement of cell D N A repli cation 
B ,11]. We ado pted this method for our purpose usi ng in vivo 
ldU injections. Cells that inco rporated BrdU were revealed on 
~I; sections by anti-Brd U monoclonal antibody coupled with 
I ' Ic' To limit our evaluations to th e LC, OKT-6 antibody, a 
ll g ll y specific marker of human LC [12] was used. T his im-
~luno l og i c meth od proved to be adeq uate since, in control sec-
IOns, no cross-reactivity between the antibodies could be dem-
onstrated. Indeed , when OKT-6 antibody was suppressed in the 
SCnes f s 0 reagents or rep la ced by a monoclonal antibody of the 
~n~e Ill1munoglobulin cl ass (lgG I ) which does not react with ~ l\~. human skin , no labeling of LC was observed . Moreover, 
st
l 
s In sections of animals not inj ected w ith BrdU , the nu clear 
alnlng b d tl Was a sent. Furtherm ore, the use of H C l to enaturate 
tl~ ~ cellular D NA, so that the monoclonal anti-Brd U ca n bind to 
d e ~l corporated Brd U (th e antibody does not bind to Brd U in 
01~-ie-stranded DNA), did not substantially alter the TRtTC-
T -6 fluorescence distribution. 
St . he nu clei ofOKT -6( - ) cells (keratinocytes) were also heavil y 
inaillcd w ith anti-BrdU antibody and their number increased dur-
III g progression of the continuous-labeling p·rocedure. We esti-
4.~d the number o f BrdU-Iabeled basa l cells only at days 2 and 
pa ~e CO Unts obtained (13% and 18%, respectively) were CO Ill -
th ra Ie with those repo rted by Brigga m;ln an d Kelly [13] usin g 
co~ sa me human skill model, but continuous [3H]thymidine in-
Poratlon. 
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Table I. M ea n Percentage of B rdU-Labeled 
La nge rh ans Cell s in Control , Stripped , or 
TPA-Treated H um an Sk in G rafts 
Contro l Stri pping" TPA Applicat ion /o 
4.9 S.2 11.2 
"Transplanted human skill was s tripped 20 tinlcs with a tr1t1Sp:u Cllt adhesive. tape 
and llrdU was inj ected 48 h later. G rafts were excised 6 h :!fter BrdU inj ectio n . and 
the percentage of OK1'-6 + UrdU + cells was eva lu ated . 
/'0 11(' hun dred n;lIl o lll o lcs o f TPA il1 15 "LI o f ::lCL'tOIl C W;lS :lpp licd to pica ll y and 
UrdU was inj ected 48 h late r. G rafts were excised 6 h a[ter BrdU inj ection , and the 
percentage of BrdU-labekd LC was eva luated. 
It was intercsting to in vestigate the influence of chemi ca l or 
mechanical st imuli on LC kinetics . Fo r this purpose, either TP A 
or strippin g were applied and the nUlll ber ofLC in S-phase (OK T -
6 + BrdU + cells) was estimated after 48 h. The period of 48 
h was chosen beca use maxim al increase of epidermal proliferation 
fo ll owing strippin g o r TPA appli cation on human skin grafted 
onto the nude mouse was obse rved at this time [141. As dem-
onstrated in Table I, TPA treatment induced a more than 100% 
increase of LC in S-phaseo Strippin g was less effective; neverthe-
less, an increase from 4.9% to 8.2% of BrdU( +) LC was also 
observed here, confirming the data repo rted by Gschnait and 
B renn er [15] o. guinea pig LC, 
Interestingly, w hatever the celJ type, the proli feration control 
seems to be exhorted at the level of the tissuc. 
T he mitotic activity of LC in the epidermis has been reported 
in on ly a few studies [1 6, 17]. T hese rather accidental observations 
of LC in mitosis arc probably due to the rarity of these cells in 
the epider mis as well as to the short ti me in which mitosis is 
accomplished . T hus, the probability of flllding a LC in mitosis 
is extremely low. In the present stud y, to increase this probability, 
we used TPA-treated grafts as well as inj ection of colchicine to 
block cells in metap hase. T hen, semi thin skin sections were ob-
served by light microscopy and selected areas processed for elec-
tron microsco pic examination . Among 1000 LC (in suprabasal 
position, clear cytoplas m) that we observed (magnifi cation x 
630), 4 cells presented mitotic figures. All 4 of these cells under 
Figure 3. Electron micrograph of LC undergoi ng mi tos is. Bar = I JLIl1 . 
Itlset, Bg = Birbeck granules. Bmo = 0.2 JLI11. 
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the electron mi croscope were fo und to conta in B irbeck g ranul es 
and, the refo~e, to be LC O ne of these cells is shown in Fi g 3. It 
presen ts d ense clumps of chro matin ; th e nucl ea r en velope has 
already disappea red and the nucl eo lus is no lo nger di stinct. T his 
s tate co rresponds to either late prom etaphase o r ea rly m etaphase. 
It has been docum ented in mice [1 8, 19] as well as in hum ans 
[20,211 that epiderma l LC o ri gin ate f rom the bo ne m arrow. K atz 
et 3J [1 9] s uggested th at LC a re not a s tab le resident cell po pulatio n 
of the epidermis but mi g rate fro m the bo ne m arrow in to the skin , 
w here they arc continuo usly rep laced at an as yet unknown rate . 
Acco rdin g ly, the o bservatio ns of LC crossin g the derma l-epi-
derma l j un ctio n as well as their presence in th e d ermis has been 
exp lain ed b y th eir mig ration in to the epidermis [22] . N everthe-
less, the inve rse directio n from the ep idermis to the dermis has 
also to be cons idered [23]. Bearin g in mind also the an tigen-
presen t in g ca pacities of LC and their immuno logic ro le in the 
epidermis 1'24], the move ment of LC from the epidermis to the 
dermi s and adja cent ly mph nodes see m s to be more probable. 
M oreover, th e large body of ev idence already cited as well as the 
present s tudy demonstrate th at LC are an actively cyclin g (passin g 
thro ug h th e S-phasl' and cell division) cell population in normal 
epide rmis. Furthermore, we also demonstrate in this s tud y that 
a ll LC arc cyclin g and that th ey arc a s table, self-reproduci ng cell 
populatio n in normal epide rmis. 
In addition, we report for the first time an es tim ation of the 
LC cycle parameters. T he total cell cycle time of LC we extrap-
o lated fro m o ur d ata (16.3 days) is nea rl y tw ice that reported fo r 
hum an keratinocytes [25 ,26], indi ca tin g that LC are a rather slow-
cyclin g cell popul ation. A ccording ly , the observatio ns that a rel-
atively lo ng perio d is necessa ry for th e PUV A (psora len plus 
ultravio le t A)-treated skin to rega in the normal popu lation of LC 
127,281 arc in agreem ent w ith this later findin g. 
It sho ul d be m en tioned fina ll y that th e above o bservat io ns are 
no t in co mpatible with th e fact th at LC mi g rate, in addition , from 
th e bone m arrow, c. g . , unde r circu I11s tan ces othcr than em bry-
ogenesis s uch as bone m arrow reconstituti o n of lethall y irradi a ted 
subjects. It m ay be suggcs ted also that pro bably o th er tox ic s tim-
uli such as serio us therm al injury and co nsequent loss of the 
ep iderm is m ay indu ce LC productio n in th e bo nc m arrow and 
subseq uently invokc their mi g ration in to th e skin . H owever, o nce 
LC reach the skin they constitute a s table , self-reproducing cell 
popu lat io n , w hich seem s to be submit ted to th e sa me local pro-
liferatio n controls as the m ajor epidermal cell compon ent kerat-
inocytes . 
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0 111' experillfellta l desigll , F. Berncl'd alld C. Dcsbas jol' their va illable assistal/ cc , 
as lIIell as M. Flnlwgal/ nI"dJ . FOlllon jo l tlIC/'r helplllith the preparatiol/ oJ this 
lIIal/l/script . 
REFERENCES 
] . Czernielewski JM , Vaigot P, Prunieras M: Epidermal Langerhans 
ce lls-a cycl ing cell population. J In vest Derm atol 84:424-426, 
1985 
2. Czcrnielews ki JM , Demarchez M, Prunieras M: Hum an Langerhans 
cel ls in epidermal cell culture, skin explants and skin grafts onto 
nude mouse. Arch Dcrmatol Res 276:288-292, 1984 
3. Gelfant S: "Of mice and men" the cel l cycle in human epiderm is iI/ 
lIivo. J Invest Dcrmatol 78:296-299, ]982 
4. Krueger G, Daynes R, E mam M: Biology of Lan gerhans cells: se-
lective migration of Langerhans cel ls into allogeneic and xeno-
geneic grafts on nude mice. Proc Nat! Acad Sci USA 80:1 650-1654, 
1983 
THE JOURNAL OF IN VEST IGATIV E D E I~ M ATOLOGY 
5. Krueger G, Ema m M: Biology of Langerhans cells: ana lys is by ex-
perim ents to deplete La ngerhans cel ls frol11 human skin . J In ves t 
Dermatol 82:6 13-6 17, 1984 
6. MacKenzie IC: Labelling of murine epidermal Langerhans cells with 
3H-th ymidine. Am J Anat 144: 127-136, 1975 
7. Potten CS, Wichmann HE: Cel l kin etic studies in the epidermis. 
T he continuous labelling method; theory and practice, Pso rias is: 
Cell Proli ferat ion. Ed ited by NA Wright, RS Ca ll1plejohn . Lon-
don, C hurchill Li vingstone 1983, pp 45-56 
8. Giaco metti L, Monta gna W: Langerhans cells: up take of tritiated 
thymidine. Science 157:439-440, 1967 
9. Schcllander F, Wolff K: Z ur auto radiographischen Mark ierun g VO Il 
Lan gerhans-Zellen mit 3H-Thymidin . Arch I<lin Exp Dcrmatol 
230: 140- 145, 1967 
10. Gratzncr HG: Monoclon al antibody to 5-bromo and 5-iododc-
oxyuridine: a new reagent for detec tion of DNA rep lication. Sci-
ence 2 18:474-475, 1982 
11. Dolbearc F, Gratzner H, Pallav icini MG, Gray JW: Flow cytometric 
measurement of total DNA content and in corporated brol1lo-
dcoxy-uridine. Proc N at! Aca d Sci USA 80:5573-5577, 1983 
12. Fithian E, Kung P, Golstein G, Rubenfeld M, Fenoglio C, Edelson 
I~ : Reactivity of Langerhans cel ls with hydridoma antibody. Proc 
Nat! Acad Sci USA 78:254 1-2544, 1981 
13. Brigga man RA, Kelly T: Con tinuous thym idine labelling studies of 
normal hum an skin growth on nude mice: measurcment of cycling 
basal cc lls (abstr). J In vcs t Dermatol 78:359, 1982 
14. Krucgcr GG, Shelby J: Biology of human sk in transplanted to the 
nude mousc: I. Response to agents which modi fy epidermal pro-
li fe rat ion. J In vest Dcrmatol 76:506-510, 1981 
15. Gschnait F, Brenner W: Kincti cs of cpidermal Langerhans cells. J 
In vest Dermatol 73:566-569, 1979 
16. Konrad K, H6nigsman H: Electronenmikrosko pischer N achweis 
cineI' mitotischcn Lan gerhaus-Zelle in Il o rmalc,. mcnschlic/rc( 
Epidermis. Arch Dennatol Forsch 246:70-74, 1973 
17. Kum ak iri M, T sukinaga I, Hashim oto K, Miura Y: A Lan gcrhanS. 
ce ll in mitosis within the cpidermi, of case of lichcn amyloidos Ll s, 
Am J Dermatol 6: 195- 197, 1984 
18. Frc! inger JG, Hood L. Hill S, Frclingcr JA: Mouse epiderm al la 
molecules have a bone marrow o ri gin . N ature 282:321-323, 1979 
19. Katz SI, Tamaki K, Sachs DH: Epidermal Langerhans ce lls are dc-
rived from cel ls o rig inating in bone marrow. N ature 282:324-326. 
1979 
20. Pelle tier M, Perrcaut C, Land ry 0 , Dav id M, Mon tplaisir S: On-
togeny of hum an epiderm al Langerhans ce lls. T ransplantatio" 
38:544-546, 1984 
21. Vole-Platzer B, Stingl G, Wolff K, Hin terberger W, Schnedl VII: 
Bone marrow origin of hull1 an epiderm al Langerhans cells (abstr). 
J In vest Dermatol 82:417, 1984 
22. Murph y GF, Bhan AK , Ha rrist TJ , Mihm MC: In situ idcntifi catio" 
of T-6 positi ve cel ls in norma l hum an dermis by immunoelec-
tronmicroscopy. Br J DermatoI1 08:423-431, 1983 
23. Silberberg-Sinakin I, Thorbeckc GJ: Contact hypersensiti vity :,Ild 
Langcrhans cclls. J Invest Dermatol 75:61-68, 1980 
24. Wolff K, Stingl G: The Langerhans cel \. J In ves t Dcrmatol 80 
(suppl) :17s- 21 s, 1983 
25. Heenen M, Achten G, Galand P: Autoradiographic analys is of cell 
kin etics in human normal epiderm is and basa l cell ca rcinollla· 
Cancer Res 33:127-131, 1973 
26. Allegra F, De Panfllis G: An in vivo meth od of studying the kil1 c t~C~ 
of cell prolrferatlOn 111 norma l epIderm,s. Acta Del'm Vencrco 
(Stock h) 54:87-90, 1974 
27. No rdlund JJ , Ackles AF, Lern er AB: The effects of ul trav iolet lig'" 
and certain dru gs on la bea rin g Langcrhans ce ll s in murine epi-
dermis. Cel l Immunol 60:50-63, 198 1 
28. Friedman PS, Ford G, Ross J , Diffeys BL: Reappearance of epiderJll al 
Langerhans cells after PUV A therapy. Br J Dermatol l 09:301-308, 
1983 
